Cargando…
Haplotype Analysis of PPARγ Gene Polymorphisms and the Lipoprotein (a) Level
BACKGROUND: Lipoprotein (a) [Lp(a)], as an independent risk factor for cardiovascular disease, is more likely to be genetically determined according to the increasing evidence of epidemiologic and clinical studies in recent years. Peroxisome proliferator-activated receptor (PPAR) γ, the ligand-activ...
Autores principales: | SHEN, Chao, FAN, Wei, XIE, Hui-Jian, WU, Ming, ZHOU, Zheng-Yuan, GUO, Zhi-Rong, DONG, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119570/ https://www.ncbi.nlm.nih.gov/pubmed/30181995 |
Ejemplares similares
-
PPAR α and PPAR γ Polymorphisms as risk factors for Dyslipidemia in a Chinese han population
por: Gu, Shu-Jun, et al.
Publicado: (2014) -
Serum PPARγ level and PPARγ gene polymorphism as well as severity and prognosis of brain injury in patients with arteriosclotic cerebral infarction
por: Wei, Weiming, et al.
Publicado: (2018) -
Dual PPAR α/γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia
por: Samuelsson, O., et al.
Publicado: (2013) -
PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008) -
The Association of PPARγ Pro12Ala and C161T Polymorphisms
with Polycystic Ovary Syndrome and Their Influence on Lipid and
Lipoprotein Profiles
por: Rahimi, Zohreh, et al.
Publicado: (2018)